Repository logoGCRIS
  • English
  • Türkçe
  • Русский
Log In
New user? Click here to register. Have you forgotten your password?
Home
Communities
Browse GCRIS
Entities
Overview
GCRIS Guide
  1. Home
  2. Browse by Author

Browsing by Author "Kabak, Kamil Erkan"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Article
    Citation - Scopus: 2
    Analysis of inoculation strategies during COVID-19 pandemic with an agent-based simulation approach
    (Elsevier Ltd, 2025) Oray Kulaç; Ayhan Özgür Toy; Kamil Erkan Kabak; Toy, Ayhan Özgür; Kabak, Kamil Erkan; Kulaç, Oray
    Background: The severity of recent Coronavirus (COVID-19) pandemics has revealed the importance of development of inoculation strategies in case of limited vaccine availability. Authorities have implemented inoculation strategies based on perceived risk factors such as age and existence of other chronic health conditions for survivability from the disease. However various other factors can be considered for identifying the preferred inoculation strategies depending on the vaccine availability and disease spread levels. This study explores the effectiveness of inoculating different groups of population in case of various vaccine availabilities and disease spread levels by means of some performance metrics namely: Attack Rate (AR) Death Rate (DR) and Hospitalization Rate (HR). Method: In this study we have implemented a highly detailed Agent-Based Simulation (ABS) model that extends classical SEIR Model by including five more additional states: Asymptomatic (A) Quarantine (Q) Hospitalized (H) Dead (D) and Immune (M) which can be used as a decision support tool to prioritize the groups of the population inoculated. The approach employs the modelling of daily mobility of individuals their interactions and transmission of virus among individuals. The population is heterogeneously clustered according to age family size work status transportation and leisure preferences with 17 different groups in order to find the most appropriate one to inoculate. Three different Disease Spread Levels (DSL) (low mid high) are experimented with four different Vaccine Available Percentages (VAP) (25% 50% 75% and 85%) with a total of 84 scenarios. Results: As the benchmark under the No Vaccine case Attack Rate Hospitalization Rate and Death Rate goes as high as 99.53% 16.96% and 1.38% respectively. Corresponding highest performance metrics (rates) are 72.33% 15.95% and 1.35% for VAP = 25%, 50.25% 9.55% and 0.94% for VAP = 50%, 24.53% 2.62% and 0.25% for VAP = 75%, and 11.51% 0.002% and 0.08% for VAP = 85%. The results of our study shows that the common practice of inoculation based on the age of individual does not yield the best outcome in terms of performance metrics across all DSL and VAP values. The groups containing workers and students that represent highly interactive individuals i.e. Group (9 10) Group (9 11 10‾) and Group (9 10 11 12‾) emerge as a commonly recommended choice for inoculation in the majority of cases. As expected we observe that the higher is the VAP levels the more is the number of alternative inoculation groups. Conclusions: Findings of this study present that: (i) inoculation considerably decreases the number of infected individuals the number of deaths and the number of hospitalized individuals due to the disease (ii) the best inoculation group/groups with respect to performance metrics varies depending on the vaccine availability percentages and disease spread levels (iii) simultaneous implementation of both inoculation and precautions like lock-down social distances and quarantines yields a stronger impact on disease spread and its consequences. © 2025 Elsevier B.V. All rights reserved.
Repository logo
Collections
  • Scopus Collection
  • WoS Collection
  • TrDizin Collection
  • PubMed Collection
Entities
  • Research Outputs
  • Organizations
  • Researchers
  • Projects
  • Awards
  • Equipments
  • Events
About
  • Contact
  • GCRIS
  • Research Ecosystems
  • Feedback
  • OAI-PMH

Log in to GCRIS Dashboard

GCRIS Mobile

Download GCRIS Mobile on the App StoreGet GCRIS Mobile on Google Play

Powered by Research Ecosystems

  • Privacy policy
  • End User Agreement
  • Feedback